Friday, July 10, 2026

Drug profile · INN

dasiglucagon

dasiglucagon (ZEGALOGUE) is a glucagon receptor agonist.

EMA: approved Systemic hormonal preparations (H04) H04AA02
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — dasiglucagon
Class
Systemic hormonal preparations (H04)
Route
Patents
0
Programs
1
Data quality
0.83

Quick answer

dasiglucagon (ZEGALOGUE) is a glucagon receptor agonist.

Key facts

INN dasiglucagon
Brand ZEGALOGUE
Mechanism Glucagon receptor agonist
Target Glucagon receptor
Therapeutic class Systemic hormonal preparations (H04)
ATC code H04AA02

Mechanism of action

Glucagon receptor agonist

Primary target: Glucagon receptor

Approval history

Authority Status Date
EMA approved

Pipeline programs

  1. Dasiglucagon 4 mg/ml Phase 3 · Zealand Pharma · Children with congenital hyperinsulinism

Related & competitor drugs

  1. atazanavir sulfate Antiinfectives for systemic use (J05)
  2. colistimethate sodium Antiinfectives for systemic use (J01)
  3. covid-19 mrna vaccine Antiinfectives for systemic use (J07)
  4. daptomycin Antiinfectives for systemic use (J01)
  5. darunavir Antiinfectives for systemic use (J05)
  6. dengue tetravalent vaccine (live, attenuated) Antiinfectives for systemic use (J07)

Frequently asked questions

What is dasiglucagon?

dasiglucagon (ZEGALOGUE) is a glucagon receptor agonist.

What is the brand name for dasiglucagon?

ZEGALOGUE is a marketed brand name for dasiglucagon. Check FDA Drugs@FDA for the current US label holder and prescribing information.